Literature DB >> 1442497

Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis.

M Nakamura1, Y Kawata, H Yoshida, N Arakawa, T Koeda, T Ichikawa, T Funakoshi, K Hiramori.   

Abstract

Brain natriuretic peptide (BNP), a family of peptides with structural and biologic homologies to previously identified atrial natriuretic peptide (ANP), has been found in human cardiac tissue and plasma. To examine the secretion mechanism of these peptides, we have studied the relationship between their plasma concentrations and hemodynamic parameters before and at 0.5 and 24 hours after percutaneous transvenous mitral commissurotomy (PTMC) in 14 patients with mitral stenosis. We have also investigated the validity of measuring plasma natriuretic peptides as a means for estimating changes in hemodynamic parameters after PTMC. The procedure decreased left atrial pressure (p < 0.01) with an elevation in left ventricular end-diastolic pressure (p < 0.05). Plasma ANP levels decreased significantly after PTMC (before, 64.1 +/- 33.7 fmol/ml; at 0.5 hour, 58.9 +/- 27.7 fmol/ml; at 24 hours, 45.7 +/- 18.3 fmol/ml; p < 0.01), whereas plasma BNP levels remained unchanged after the procedure (before, 5.3 +/- 1.5 fmol/ml; at 0.5 hour, 5.6 +/- 1.9 fmol/ml; at 24 hours, 5.0 +/- 1.9 fmol/ml; p = NS). There was a significant relationship between basal plasma ANP and left atrial pressure (r = 0.88; p < 0.001), and changes in plasma ANP were correlated with those in left atrial pressure (r = 0.69; p < 0.01). Basal plasma BNP was significantly correlated with basal left ventricular end-diastolic pressure (r = 0.65; p < 0.05) but not with the other measured hemodynamic parameters or with plasma volume.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442497     DOI: 10.1016/0002-8703(92)90413-p

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.

Authors:  Osman Saribulbul; Ilker Alat; Senol Coskun; Anil Z Apaydin; Tahir Yagdi; Mefkure Kiliccioglu; Emin Alp Alayunt
Journal:  Tex Heart Inst J       Date:  2003

Review 2.  Natriuretic peptides in heart valve disease.

Authors:  S G Ray
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Sympathetic overactivity in patients with rheumatic mitral stenosis.

Authors:  Ozcan Ozdemir; Omer Alyan; Mustafa Soylu; Fatma Metin; Ahmet Duran Demir; Bilal Geyik; Dursun Aras; Cemal Ozbakir; Gökhan Cihan; Hatice Sasmaz; Sule Korkmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

4.  Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.

Authors:  C Haug; A Metzele; J Steffgen; M Kochs; V Hombach; A Grünert
Journal:  Clin Investig       Date:  1994-06

5.  Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.

Authors:  Tayfun Sahin; Eser Acar; Umut Celikyurt; Teoman Kılıc; Guliz Kozdag; Aysen Agacdiken; Dilek Ural
Journal:  Med Sci Monit       Date:  2012-02

6.  Changes in Serum NT-Pro BNP and Left Atrial BNP Levels after Percutaneous Transvenous Mitral Commissurotomy in Sinus Rhythm Versus Atrial Firilation.

Authors:  Leili Pourafkari; Seyedrazi Seyedhosseini; Babak Kazemi; Heydarali Esmaili; Naser Aslanabadi
Journal:  J Cardiovasc Thorac Res       Date:  2014-09-30

7.  ANP and BNP plasma levels in patients with rheumatic mitral stenosis after percutaneous balloon mitral valvuloplasty.

Authors:  Łukasz Mazurkiewicz; Witold Rużyłło; Zbigniew Chmielak; Ewa Opalińska-Ciszek; Jadwiga Janas; Piotr Hoffman; Tomasz Hryniewiecki; Jacek Grzybowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.